Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Tuesday, June 2, 1998 Published at 20:10 GMT 21:10 UK


Business: The Economy

Why the Russian domino can threaten Europe's markets


Rodney Smith's weekly look at Europe's economy and stock markets.

Russia ...
Russia is still on a knife edge, economically speaking ... one which could cut deeply into the rest of Europe if it slips. The key will be rouble devaluation.

Official protests aside, pressure for devaluation could soon be uncontainable. Fixing the rate at 6.10 to the dollar gave the markets a target which wasn't there before, and now they are having a go at it.

... and Europe

And, says Peter Oppenheimer at HSBC James Capel, if the rouble IS forced to devalue, many of the other Eastern European currencies which are closely linked with it would have to go too; a repeat of events in the Far East last year.

Furthermore, he says, the European Union now exports about 15% of its goods to Eastern Europe; the US exports less than 2%. Clearly, a domino devaluation in Eastern Europe could hurt Western European manufacturers.

Worst affected would be companies in the two biggest traders with Eastern Europe, Germany and Austria. Worse still, the event would not even need to happen. It need only be perceived as a sufficiently serious threat to damage confidence and sentiment in equity markets.

Deutschmark

The next step could be that the Deutschmark, the lynchpin of the Euro, slips against the already powerful dollar. Western European interest rates would eventually have to take the strain.

This will doubtless be brought to the attention of Messers Duisenberg, Issing, Hamalainen, Solans, Padoa Schioppa and Noyer. Names to remember, they are the inaugural board of the European Central Bank, busy this week preparing for next Tuesday's policy meeting.

Not that anything will happen. They don't get to pull the levers of European monetary policy until January. In the meantime, they are testing the fit and feel of the desks and the chairs.

Drugs

Otherwise, there's a sense of general awareness on European bourses of the continuing consolidation in the pharmaceuticals and banking industries. The $33bn purchase of Monsanto by AHP in the United States will create another drugs giant which will push Europeans like Zeneca farther into the background ... forcing their boards to contemplate, however reluctantly, the need for a partner if only as protection from predation.

And brokers know this.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage |


The Economy Contents

In this section

Inquiry into energy provider loyalty

Brown considers IMF job

Chinese imports boost US trade gap

No longer Liffe as we know it

The growing threat of internet fraud

House passes US budget

Online share dealing triples

Rate fears as sales soar

Brown's bulging war-chest

Oil reaches nine-year high

UK unemployment falls again

Trade talks deadlocked

US inflation still subdued

Insolvent firms to get breathing space

Bank considered bigger rate rise

UK pay rising 'too fast'

Utilities face tough regulation

CBI's new chief named

US stocks hit highs after rate rise

US Fed raises rates

UK inflation creeps up

Row over the national shopping basket

Military airspace to be cut

TUC warns against following US

World growth accelerates

Union merger put in doubt

Japan's tentative economic recovery

EU fraud costs millions

CBI choice 'could wreck industrial relations'

WTO hails China deal

US business eyes Chinese market

Red tape task force

Websites and widgets

Guru predicts web surge

Malaysia's economy: The Sinatra Principle

Shell secures Iranian oil deal

Irish boom draws the Welsh

China deal to boost economy

US dream scenario continues

Japan's billion dollar spending spree